AzTrials
AzTrials

Efficacy of Treatment of Cellulite Using Carboxy TherapyNCT05405062

Carboxytherapy Versus Short-pulsed Nd Yag Laser in Cellulite

A study testing Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision in people with Efficacy of Treatment of Cellulite Using Carboxy Therapy, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To evaluate the efficacy of carboxytherapy versus short-pulsed 1064 nm Nd-YAG laser combined with subcision in treatment of cellulite using clinical assessment and ultrasound imaging. Read more about this study

Who is it for?
Ages 18 to 60 years, women only
What is being tested?
Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
1 Jun 2022to 15 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Females between 18 and 60 years
  • Females with cellulite; stage 2 or 3 according to Nurnberger-Muller Scale (Nurnberger and Muller, 1978)

Who cannot join

  • Subjects that have had liposuction or surgical procedures to remove fat in the past 6 months
  • Personal or family history of keloid formation or scarring
  • Pregnant or lactating females
  • Significant concomitant illness (e.g. renal, cardiac, hepatic, autoimmune conditions)
  • Known history of bleeding tendency or receiving antiplatelet or anticoagulant therapy
  • History of uncontrolled diabetes
Show all 9Show fewer
  • History of thrombophlebitis within the last 2 years
  • Subjects with active infections
  • Subjects on long term corticosteroid or immunosuppressive therapy

About this study

Official title: Efficacy of Carboxytherapy Versus Short-pulsed 1064 nm Nd-YAG Laser Combined With Subcision in Treatment of Cellulite

To evaluate the efficacy of carboxytherapy versus short-pulsed 1064 nm Nd-YAG laser combined with subcision in treatment of cellulite using clinical assessment and ultrasound imaging.

Read the detailed description

Study Design:

Randomized Clinical Trial

Study Methods:

The population of study: Thirty females aged from 18 to 60 years with cellulite Study location: Dermatology outpatient clinic, Faculty of Medicine, Cairo University

Inclusion criteria:

  1. Females between 18 and 60 years
  2. Females with cellulite; stage 2 or 3 according to Nurnberger-Muller Scale

Exclusion criteria:

  1. Subjects that have had liposuction or surgical procedures to remove fat in the past 6 months
  2. Personal or family history of keloid formation or scarring
  3. Pregnant or lactating females
  4. Significant concomitant illness (e.g. renal, cardiac, hepatic, autoimmune conditions)
  5. Known history of bleeding tendency or receiving antiplatelet or anticoagulant therapy
  6. History of uncontrolled diabetes
  7. History of thrombophlebitis within the last 2 years
  8. Subjects with active infections
  9. Subjects on long term corticosteroid or immunosuppressive therapy

All patients will be subjected to the following:

An informed written consent will be obtained from all the patients.

  • Patients will be examined to assess site, stage and severity of cellulite.
  • Depressed areas on gluteal region and posterolateral thighs will be selected and marked while the patient is standing.
  • One side will be randomized to receive 6 carboxytherapy sessions with an interval of 2 weeks.
  • The other side will receive 3 sessions of short pulsed 1064 nm Nd-YAG laser (25 joules/cm2, 2.2Hz) combined with subcision with an interval of 1 month.
  • In carboxytherapy, 5 cc will be injected in each point with depth of 7mm. Between each point and the other is 5 cm.
  • Subcision will be done in the center of the selected dimples.
  • Systemic antibiotics will be prescribed for 5 days after subcision session.
  • The whole duration of the sessions is 3 months.
  • Patients will be advised to maintain a healthy diet throughout the study.

Evaluation of patients' response:

  • A complete physical examination and history taking before treatment
  • Evaluation will be carried out for each patient at the beginning of the study, and at the end of the study 2 weeks following the final session by:
  1. Standardized photography (posterior and side view)
  2. Photonumeric cellulite severity scale (Hexsel et al., 2009)
  3. Ultrasound imaging that measures percentage of reduction of subcutaneous fat and dermal thickness. The device used is Toshiba with high frequency probes: probe 18-20 MHz (for measuring skin dermal thickness) and probe 7-9MHz (for measuring subcutaneous fat thickness)
  4. Patient satisfaction scoring will be reported at the end of the study by patient satisfaction score (excellent, very good, good, bad, very bad) and DLQI score (Finlay and Khan, 1994).

Potential risks:

  1. Ecchymosis
  2. Pain
  3. Burning sensation

3- Secondary infection at injection site

Study outcomes:

  1. Assessment of efficacy of carboxytherapy in the treatment of cellulite (clinically by photography and photonumeric severity scale).
  2. Evaluating possible synergistic effect of short pulsed Nd-YAG laser combined with subcision in treatment of cellulite (clinically by photography and photonumeric severity scale).

Secondary outcome:

Comparing the reduction in subcutaneous fat and change in dermal thickness between the 2 methods by ultrasound imaging.

Being tested
Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Carboxytherapy, short pulsed 1064 Nd Yag laser and subcisionDevice

    Carboxytherapy is involves the injection of carbon dioxide into the subcutaneous tissue, with the goal of affecting the adipose tissue and circulation. Its mechanism of action is through an increase in capillary blood flow induced by hypercapnia and a decrease in cutaneous oxygen consumption (Pianez et al., 2016).

Study groups in NCT05405062
Study groupRoleWhat they receive
CarboxytherapyActive comparatorSix carboxytherapy sessions with an interval of 2 weeks. Five ccs will be injected at each point with a depth of 7mm. Between each point and the other is 5 cm.
Receives: Device: Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision
Short pulsed 1064 nm Nd-YAG laser combined with subcisionActive comparatorTwenty-five joules/cm2, 2.2Hz combined with subcision with an interval of 1 month.
Receives: Device: Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Photonumeric cellulite severity scale

    Measured: Change from baseline at 3 months

Secondary outcomes (1)
  1. Ultrasound imaging

    The device used is Toshiba with high frequency probes: probe 18-20 MHz (for measuring skin dermal thickness) and probe 7-9MHz (for measuring subcutaneous fat thickness)

    Measured: Change from baseline at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2022
  2. Study start1 Jun 2022 (estimated)
  3. Primary completion15 Sep 2022 (estimated)
  4. Study completion15 Sep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05405062
Sponsor's protocol ID
Carboxy therapy and cellulite
Status last verified
Jun 2022
First submitted
7 Jan 2022
Last updated
3 Jun 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision in people with Efficacy of Treatment of Cellulite Using Carboxy Therapy, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Photonumeric cellulite severity scale (time frame: Change from baseline at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in